Table 3 Clinical characteristics of Group II patients before VPS and one weeks after VPS
Patient | Before VPS | one week after VPS | P-value |
|---|---|---|---|
CSF parametersopening pressure | |||
≥ 25 mH2O(n, %) | 33 (84.6%) | 12 (30.8%) | 0.000* |
CSF WBC count×106/l (med, range) | 66 (4–620) | 77 (0–993) | 0.220 |
≥20 (n,%) | 36 (80.0%) | 41 (91.1%) | 0.136 |
CSF protein g/l (med, range) | 0.67 (0.22–4.08) | 2.29 (0.08–729) | 0.000* |
CSF glucose mmol/l (med, range) | 1.16 (0.01–3.47) | 0.91 (0.01–4.86) | 0.380 |
CSF cryptococci count/ml (med, range) | 9533 (0–263,000) | 2066 (0–235,000) | 0.019* |
CSF culture positive (+) (n, %) | 19 (48.7%) | 6 (15.4%) | 0.002* |
BMR staging (n = 39) | 0.026* | ||
1 | 8 (20.5%) | 14 (35.9%) | |
2 | 10 (25.6%) | 14 (35.9%) | |
3 | 21 (53.8%) | 11 (28.2%) | |
Complications after VSP (n, %) | NA | 20 (44.4%) | NA |
Fever 3 days after VPS | NA | 16 (35.6%) | NA |
Over-shunting | NA | 2 (4.4%) | NA |
Obstructed shunt | NA | 3 (6.7%) | NA |
Secondary abdominal infection | NA | 1 (2.2%) | NA |